Carregant...
Hydroxychloroquine, COVID‐19 and diabetes. Why it is a different story
Hydroxychloroquine has been proposed for the cure of the COVID‐19 due to its anti‐inflammatory and anti‐viral action. People with diabetes are more prone to severe outcome if affected by COVID‐19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxych...
Guardat en:
| Publicat a: | Diabetes Metab Res Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362015/ https://ncbi.nlm.nih.gov/pubmed/32592507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dmrr.3379 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|